Shares of Indivior PLC (LON:INDV – Get Free Report) crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 1,238 and traded as low as GBX 1,230. Indivior shares last traded at GBX 1,238, with a volume of 8,457,898 shares traded.
Indivior Price Performance
The company has a market capitalization of £1.93 billion, a P/E ratio of -1,026.48, a PEG ratio of -5.57 and a beta of 0.19. The company has a quick ratio of 1.52, a current ratio of 0.90 and a debt-to-equity ratio of -141.86. The firm has a 50-day moving average price of GBX 1,238 and a two-hundred day moving average price of GBX 1,238.
About Indivior
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose. Its core marketed products include SUBLOCADE and SUBUTEX PRO buprenorphine extended-release monthly injections; SUBOXONE, a buprenorphine and naloxone sublingual film; SUBOXONE, a buprenorphine and naloxone sublingual tablet; and SUBUTEX, a buprenorphine sublingual tablet for the treatment of opioid use disorder.
Read More
- Five stocks we like better than Indivior
- Starbucks Builds Sovereign AI to Cut $400 Million in Software Costs
- Power Struggle: Wolfspeed Sues Navitas Over AI Chips
- Why WD-40 Is Proving Great Businesses Never Go Out of Style
- Pushing the Edge: Super Micro Computer Reboots the AI Landscape
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.
